Mobile Phone Technology for Prevention of Mother-to-Child Transmission of HIV: Acceptability, Effectiveness, and Cost
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- HIV
- Sponsor
- Elizabeth Glaser Pediatric AIDS Foundation
- Enrollment
- 600
- Locations
- 1
- Primary Endpoint
- The proportion of women who successfully complete key PMTCT transition points from antenatal to six weeks postpartum.
- Status
- Completed
- Last Updated
- 11 years ago
Overview
Brief Summary
Although gains have been made in achieving the health-related Millennium Development Goals (MDG), much is still needed in countries affected by high levels of HIV/AIDS. Prevention of mother-to-child transmission (PMTCT) is a cornerstone strategy in reducing infant mortality from HIV. The study will employ a cluster randomized control trial (cRCT) with 26 health facilities randomized to two arms (intervention or control) to determine the effect of mobile phone technology on completion of key PMTCT milestones from antenatal to six weeks postpartum. The study will examine the acceptability, effectiveness, and cost of implementing a PMTCT-focused mHealth strategy among HIV-infected pregnant women, health workers, and male partners.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
The proportion of women who successfully complete key PMTCT transition points from antenatal to six weeks postpartum.
Time Frame: ~ 6 months
Initiation of Infant prophylaxis, Facility delivery and receipt of results of 6 weeks early infant diagnosis by DNA PCR
Time Frame: ~ 6 months
Secondary Outcomes
- Uptake ARV prophylaxis/ART during labor, delivery, and postpartum(~ 6 months)
- Self-reported maternal adherence to ARV prophylaxis/ART during pregnancy(~ 4 months)
- Time to initiation of ARV prophylaxis/ART uptake after initial identification of HIV seropositivity within ANC(~ 1 month)